IPSEN |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113 EUR | +0.62% |
|
+4.24% | +4.73% |
| 04-24 | IPSEN : Better-than-expected Q1; guidance unchanged |  |
| 04-24 | Transcript : Ipsen S.A., Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024 |
Chart calendar Ipsen
60ab5d06c7.ydHH3Dv6ZeIS-ijJvEeINjeOWeX4NUyRXs5gvUpRrnA.-qmimF6ZDrZhyFKt4zP5BHjPaoCZZhnFJ-Ml7R4j5AX9lq67SK4gikO4Rw~fc07eec3dbfbf19962033e6c44d1b000
Upcoming events on Ipsen
Past events on Ipsen
| 24/04/2024 12:00 | Q1 2024 Sales and Revenue Call |
| 24/04/2024 06:00 | Q1 2024 Sales and Revenue Release |
| 11/03/2024 | Barclays Global Healthcare Conference |
| 04/03/2024 | TD Cowen Health Care Conference |
| 27/02/2024 | Morgan Stanley European MedTech and Life Sciences Conference |
| 26/02/2024 | Non Deal Roadshow |
| 21/02/2024 | Non Deal Roadshow |
| 20/02/2024 | Non Deal Roadshow |
| 08/02/2024 13:00 | Q4 2023 Earnings Call |
| 08/02/2024 05:58 | Q4 2023 Earnings Release |
| 24/01/2024 | American Society of Clinical Oncology Genitourinary Symposium - Abstract #18 |
| 11/01/2024 | ODDO BHF Forum |
| 07/01/2024 | JPMorgan Healthcare Conference |
| 07/12/2023 12:30 | Capital Markets Day |
| 14/11/2023 15:30 | American Association for the Study of Liver Diseases Conference |
| 13/11/2023 21:45 | American Association for the Study of Liver Diseases Conference - Abstract #484 |
| 08/11/2023 14:00 | Deutsche Bank Depositary Receipts Virtual Investor Conference |
| 26/10/2023 13:00 | Q3 2023 Sales and Revenue Call |
| 26/10/2023 06:00 | Q3 2023 Sales and Revenue Release |
| 13/09/2023 | Bank of America Global Healthcare Conference |
Past dividends on Ipsen
| 01/06/2023 | Annual 1.2 EUR |
| 30/05/2022 | Annual 1.2 EUR |
| 30/05/2021 | Annual 1 EUR |
| 02/06/2020 | Annual 1 EUR |
| 30/05/2019 | Annual 1 EUR |
| 03/06/2018 | Annual 1 EUR |
| 08/06/2017 | Annual 0.85 EUR |
| 01/06/2016 | Annual 0.85 EUR |
| 28/05/2015 | 0.85 EUR |
| 08/06/2014 | Annual 0.8 EUR |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 2 576 2 608 -1.23% | 2 592 2 622 -1.14% | 2 869 2 883 -0.5% | 3 025 3 069 -1.45% | 3 128 3 273 -4.45% | 3 445 |
|
EBITDA Million EUR | Released Forecast Spread | 944 910 3.69% | 978 910 7.45% | 1 166 1 095 6.52% | 1 348 1 247 8.12% | 881 1 142 -22.84% | 1 210 |
|
EBIT Million EUR | Released Forecast Spread | 783 775 0.96% | 829 795 4.26% | 1 011 954 6% | 1 115 1 090 2.31% | 1 001 974 2.79% | 1 014 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -38,5 580 -106.64% | 529 586 -9.75% | 815 829 -1.74% | 706 945 -25.3% | 762 698 9.04% | 764 |
|
Net income Million EUR | Released Forecast Spread | -50,7 465 -110.91% | 548 462 18.67% | 647 622 3.98% | 648 804 -19.44% | 647 598 8.27% | 645 |
|
EPS EUR | Released Forecast Spread | -0,61 5,76 -110.6% | 6,57 5,54 18.52% | 7,76 7,45 4.17% | 7,81 9,69 -19.37% | 7,73 7,03 9.9% | 7,75 |
| Announcement Date | 13/02/20 | 11/02/21 | 11/02/22 | 09/02/23 | 08/02/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 1 347 1 374 -2% | 1 268 1 293 -1.88% | 1 323 1 339 -1.14% | 1 350 1 333 1.3% | 791 722 9.56% | 1 519 1 502 1.11% | 688 661 4.07% | 746 725 2.86% | 1 434 1 466 -2.2% | 775 747 3.79% | 816 790 3.34% | 1 591 1 621 -1.83% | 742 709 4.64% | 795 780 1.94% | 1 537 1 528 0.56% | 772 783 -1.4% | 819 | 1 591 1 691 -5.89% | 822 788 4.31% |
|
EBITDA Million EUR | Released Forecast Spread | 321 79,2 305.43% | ||||||||||||||||||
|
EBIT Million EUR | Released Forecast Spread | 395 391 1.02% | 410 381 7.71% | 419 390 7.37% | 480 426 12.59% | 532 476 11.56% | 568 509 11.66% | 547 540 1.45% | 523 528 -0.91% | 478 431 10.91% | ||||||||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -321 314 -202.37% | 270 367 -26.41% | 259 343 -24.51% | 401 402 -0.3% | 414 433 -4.46% | ||||||||||||||
|
Net income Million EUR | Released Forecast Spread | -271 250 -208.32% | 223 299 -25.47% | 325 265 22.77% | 304 259 17.37% | 343 345 -0.81% | 253 514 -50.69% | |||||||||||||
|
EPS EUR | Released Forecast Spread | -3,25 3,01 -207.97% | 2,66 3,11 -14.33% | 3,91 3,10 26.33% | 3,64 3,34 8.98% | 4,12 4,10 0.49% | 3,07 8,33 -63.15% | 2,35 4,27 -44.96% | 5,38 3,48 54.82% | |||||||||||
| Announcement Date | 13/02/20 | 30/07/20 | 11/02/21 | 29/07/21 | 11/02/22 | 11/02/22 | 27/04/22 | 28/07/22 | 28/07/22 | 27/10/22 | 09/02/23 | 09/02/23 | 27/04/23 | 27/07/23 | 27/07/23 | 26/10/23 | 08/02/24 | 08/02/24 | 24/04/24 |
More events
Past sector events for Ipsen
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IPN Stock
- Calendar Ipsen
